PKP2 and arrhythmogenic right ventricular cardiomyopathy: Here, through the generation of a PKP2 genetic mouse model, we highlight the sufficiency and molecular mechanisms by which a prevalent human PKP2 RNA splice acceptor site mutation (PKP2 IVS10-1G>C) triggers the postnatal onset of ARVC.